Skip to content

Efficacy of Gudadi mandur vati will be check on iron deficiency anemia in pregnancy patients

Randomized controlled clinical trial to evaluate the efficacy of Gudadi mandur in the management of garbhini pandu (iron deficiency anemia in pregnancy) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/075582
Enrollment
92
Registered
2024-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O990- Anemia complicating pregnancy, childbirth and the puerperium Health Condition 2: O269- Pregnancy related conditions, unspecified

Interventions

None listed

Sponsors

C.S.M.S.S. Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Diagnosed Patients Of Garbhini Pandu 2.Pregnant Women Of 21 TO 40 Years Age. 3. Patients In Between 14 Weeks To 30 Weeks Of Preganancy. 4. Hb% Above 7gm% And Below 10 gm%.

Exclusion criteria

Exclusion criteria: 1. Patients Suffering From Severe Aenemia Hb Below 7 gm %. 2. Age Of Garbhini Below 21 Years And Above 40 Years. 3. Anemia Due To Major Disease , Known Case Of Thalassemia, Sickle Cell Anemia, Pernicious Anemia, Aplastic Anemia And Other Complications Like Bleeding Piles And Twin Pregnancy. 4.Any Other Obstetric Complication Like Pre-Eclampsia, Gestational Diabetes. 5. Patients With HbsAg , HIV, VDRL Positive. 6. Any Major Diseases that Interfere With The Corse Of Treatment.

Design outcomes

Primary

MeasureTime frame
Hb % will increaseTimepoint: 1 month

Secondary

MeasureTime frame
Lakshanas of garbhini pandu will dicrease.Timepoint: 2 months

Countries

India

Contacts

Public ContactDr Rutuja Ramchandra Yamgar

C.S.M.S.S Ayurved Mahavidyalaya and Rugnalaya Kanchanwadi Aurangabad Maharashtra India 431001

dr.jayashrisdeshmukh@gmail.com9325580777

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026